This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$464K
Filings
20
Firms Hired
2
Active Period
2023–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Privacy Enhancing Technology Research Act
2024 · first_quarter · Firm: DATAVANT INC.
Privacy Enhancing Technologies (PETs), including S.244 - Promoting Digital Privacy Technologies Act and H.R. 4755 - Privacy Enhancing Technology Research Act. The use of AI in healthcare; Data privacy; Interoperability.
Client expense: $78,125 · Firm income: —
Matched citations: H.R. 4755
Privacy Enhancing Technologies (PETs), including S.244 - Promoting Digital Privacy Technologies Act and H.R. 4755 - Privacy Enhancing Technology Research Act. The use of AI in healthcare; Data privacy; Interoperability.
Client expense: $78,125 · Firm income: —
Matched citations: S.244
Privacy Enhancing Technology Research Act
2023 · fourth_quarter · Firm: DATAVANT INC.
Privacy Enhancing Technologies (PETs), including S.3325 - Promoting Digital Privacy Technologies Act and H.R. 4755 - Privacy Enhancing Technology Research Act. The use of AI in healthcare; FTC rule making 3rd party access.
Client expense: $48,650 · Firm income: —
Matched citations: H.R. 4755
Promoting Digital Privacy Technologies Act
2023 · fourth_quarter · Firm: DATAVANT INC.
Privacy Enhancing Technologies (PETs), including S.3325 - Promoting Digital Privacy Technologies Act and H.R. 4755 - Privacy Enhancing Technology Research Act. The use of AI in healthcare; FTC rule making 3rd party access.
Client expense: $48,650 · Firm income: —
Matched citations: S.3325
Source: Senate LDA